Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-22

Clinical Trial Update: A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating preliminary eradication of Helicobacter pylori using TNP-2198 with rabeprazole and comparisons to rabeprazole plus amoxicillin; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNP-2198 capsules
  • amoxicillin capsules (amoxicillin)
  • rabeprazole sodium enteric-coated tablets (rabeprazole)

Snippet

Sponsor: TenNor Therapeutics (Suzhou) Limited | Conditions: Helicobacter Pylori Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-22